New heart drug shows promise for genetic heart condition
NCT ID NCT06347159
Summary
This study is testing an experimental drug called EDG-7500 in 100 adults with hypertrophic cardiomyopathy (HCM), a genetic condition where the heart muscle thickens and can cause serious symptoms. Researchers want to understand if different doses are safe and how they affect heart function and blood flow. The study focuses on people with both obstructive and non-obstructive forms of HCM who have moderate symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Womens Hospital
Boston, Massachusetts, 02115, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Duke Health Center Arringdon
Morrisville, North Carolina, 27560, United States
-
Emory Clinic
Atlanta, Georgia, 30322, United States
-
Hospital of the University of Pennsylvania (University of Pennsylvania School of Medicine)
Philadelphia, Pennsylvania, 19104, United States
-
Lahey Hospital and Medical Center
Burlington, Massachusetts, 01805, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Michigan Medicine - Michigan Clinical Research Unit
Ann Arbor, Michigan, 48109, United States
-
Morristown Medical Center (Atlantic Health System)
Morristown, New Jersey, 07960, United States
-
NYU Langone Health Medical Center - HCM Program Office (Study open to existing NYU patients only)
New York, New York, 10016, United States
-
North Shore University Hospital
Manhasset, New York, 11030, United States
-
Oregon Health & Science University (OHSU)
Portland, Oregon, 97239, United States
-
Saint Luke's Hospital of Kansas City
Kansas City, Missouri, 64111, United States
-
Sanger Heart and Vascular Institute
Charlotte, North Carolina, 28204, United States
-
Stanford University Hospital / Stanford Health Care
Stanford, California, 94305, United States
-
The Lindner Research Center at Christ Hospital
Cincinnati, Ohio, 45219, United States
-
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 33612, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Virginia Heart and Vascular Center Fontaine
Charlottesville, Virginia, 22903, United States
-
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
Conditions
Explore the condition pages connected to this study.